Olivier Jarry Email & Phone Number
@liberabio.com
1 phone found area 914
LinkedIn matched
Who is Olivier Jarry? Overview
A concise factual answer block for searchers comparing this professional profile.
Olivier Jarry is listed as Chief Executive Officer and Co-Founder at LiberaBio, a company with 10 employees, based in New York, New York, United States. AeroLeads shows a work email signal at liberabio.com, phone signal with area code 914, and a matched LinkedIn profile for Olivier Jarry.
Olivier Jarry previously worked as CEO and Co-Founder at Liberabio and COO at Advantage Therapeutics Inc.. Olivier Jarry holds Master Of Business Administration (M.B.A.), Executive Mba, International Business from Trium Global Executive Mba.
Email format at LiberaBio
This section adds company-level context without repeating Olivier Jarry's masked contact details.
AeroLeads found 1 current-domain work email signal for Olivier Jarry. Compare company email patterns before reaching out.
About Olivier Jarry
Olivier leverages 35+ years of passion improving health and living standards throughout Western / Eastern Europe, the Americas, India, Asia - delivers top / bottom line growth (P&L up to USD 1.4 billion),- starts new businesses (up to USD 0.8 billion), - concludes M&A transactions (up to USD 1.1 billion, 16+ successful post-merger integrations), - drives large enterprise transformations / turnarounds, - innovates with digital technologies, - orchestrates strategic planning, strategic marketing, business development (up to USD 6 billion)- raises funds for biotech, medtech (USD 40+ million to date)Boards: • Imagiance LLC (dba 3xBL Enterprises)- Principal• Fit4D – Board Member, Advisor (adherence coaching for people with diabetes)• MergerWorks – Advisor (M&A consulting)• Foundation Ventures – Advisor (investments)• Atlas Advisors – Advisor (investments)• NYU Marketing Committee – Board member (education)• Executive Forum – Board member (prof. association)• AdvaMed Dx – former Board member (prof. association)• AFNOR/ISO – former committee member on Project Management standardizationSpecialties: Organic Growth | Turnarounds | Corporate Mergers & Acquisitions (M&A) | Post-Merger Integration (PMI) | Corporate Strategy | Strategic Planning / Operations Planning / Business Planning | Alliances and Joint-Ventures | Business Development | Start-Ups | Funding | Exit Strategies | Angel Investor / Venture Capital (VC) / Private Equity (PE) | New Products / launches | New Sales Channels / Markets | Emerging Markets | Bottom-Of-the-Pyramid ("BOP") | For-profit | Non-for-profit Boards | Multiple Expansion | Revenue Acceleration | Margin Enhancement | EBITDA Improvement | P&L Responsibility | Global Chief Operating Officer (COO) | International Senior Vice-President (SVP) | Pharmaceuticals (Rx) | Generics (Gx) | Vaccines (Vx) | Medical Devices / Diagnostics (Dx) | Over The Counter medicines (OTC) | Treatment Adherence / Behavior Change (Bx) | FMCG / CPG / Consumer Products | Industrial Products | Electronics / Automation | Fortune 50 | B2C | B2B
Listed skills include Product Marketing, Marketing Management, International Business, Restructuring, and 46 others.
Olivier Jarry's current company
Company context helps verify the profile and gives searchers a useful next step.
Olivier Jarry work experience
A career timeline built from the work history available for this profile.
Ceo And Co-Founder
CurrentSupporting the organization and development of this pre-clinical oncology company that has patented the MPN Technology for the actively-targeted delivery of biologics (and small molecules) to tumor and metastatic cells, and even more importantly to intracellular oncoproteins (such as KRAS), until now considered "undruggable". Several assets co-developed.
Coo
CurrentADvantage Therapeutics is developing therapies to treat neurodegenerative conditions with a major focus on Alzheimer’s Disease (AD). We are currently preparing for clinical trials in Europe and in the US. Furthermore, ADvantage is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.
Cfo
CurrentRational Vaccines develops therapeutic and prophylactic vaccines against herpes simplex viruses HSV-1 and HSV-2. These vaccines are based on engineered live attenuated viruses designed for safety and immunogenicity. 4+ billion individuals are estimated seropositive to herpes, which may manifest itself as breakouts, neuropathy or even encephalopathy..
Non Executive Director
CurrentOS Therapies (OST) is a clinical-stage cancer immunotherapy company dedicated to developing a new way of activating the immune system to kill cancers that express HER2 like Osteosarcoma, Breast Cancer, Colorectal Cancer and other solid tumors. With over 30 years of without new treatments in Osteosarcoma, we are first addressing this urgent need for.
Managing Director
CurrentAtlas Advisors provides its clients with advisory capabilities across North America, Europe, Latin America and Asia.Drawing on the deep and broad experience of our professionals, we are active across the full range of M&A advisory roles, including acquisitions, mergers, joint ventures, minority investments, asset swaps, divestitures, distressed sales.
Member (Formerly On Board)
Board Member Ny/Nj
Managing Partner - Life Sciences, Market Research, Global Access-To-Medicines, Sdg
- PHYSICIAN ENGAGEMENT. Processes and systems to develop physicians personally and professionally.- PATIENT ENGAGEMENT. Processes and systems to improve health outcomes and satisfaction for patients, while containing costs for the healthcare system ("triple aim").- ACCESS TO HEALTHCARE. Design and implement programs to increase access to healthcare for low.
Member
President & Chief Commercial Officer
Launched B2B channels for Dario: Employers, Payers, Healthcare Providers, Drugstores, as well as several alliances with large organizations.
Senior Adviser - Business Development & Alliances
DarioHealth Corp. (NASDAQ:DRIO) is a leading Global Digital Therapeutics (DTx) company revolutionizing the way people with chronic condition manage their health.By delivering personalized evidence-based interventions that are driven by precision data analytics, high quality software, and personalized coaching, DarioHealth has developed a novel approach.
Senior Advisor (Investment Banking, Life Sciences)
Investment banking in biotechnology, medical technology, digital health. (FINRA registered Series 7, 63, 79)
Non-Executive Director (Board Member) - Business Development & Alliance
LIFNano Therapeutics was founded in 2013 as a spin-out from the University of Cambridge, progressing to a clinical stage Nano-Bio-Med company specifically focused on targeted delivery of the biologic, Leukaemia Inhibitory Factor (LIF).Following the Founder's discovery that LIF is of profound importance in immune self-tolerance in addition to the known key.
Chief Executive Officer
Senior Adviser - Pharmaceuticals Consulting, Market Access, Product Launches, Health Economics
Strategic Planning. Health economics. Outcomes studies (retrospective, prospective, predictive). Value of diagnostics.
Partner Skipta Global
Expanding internationally a universe of social networks that allow verified healthcare professionals to collaborate with each other within their medical specialty, and life sciences companies to engage in a dialogue with them.Exit via divestiture to Informa plc.
Svp Consumer Sector
"Whether engineering novel therapies for health, delivering unique solutions to address global energy demand, enabling unparalleled productivity advancements in food, or developing innovative applications in the consumer and environment sectors, Intrexon is working diligently today to create a better tomorrow.”
Head Strategy, Operations, Market Access / Emerging Markets
- Led Commercial Operations for a USD 1 billion division with fast growing, innovative medicines- Updated 10-year strategy for exponential growth. Local alliances and acquisitions. - Evaluated new pricing approaches such as tier pricing and enhanced Patient Accessibility Programs (PAPs).- Re-launched the Market Access function for Emerging Markets.
Global Division Head - Diabetes Care
- Led sustainable, profitable growth in all regions for a USD 1.5 billion business unit. Evaluated new ways to reach the market / create new market segments. Aligned the portfolio of products and services to new strategies. Explored possible partnerships, alliances, acquisitions. Adapted the talent pool.- Launched five acclaimed (New York Times, Wall.
Head Western/Eastern Europe, Vaccines (Incl. Russia, Cis)
- Grew the vaccines market share in more than 30 countries. Addressed the requests for H1N1 pandemic flu vaccines from numerous governments.- Restructured the region for its next phase of growth, including new launches, while maintaining internal headcount to the minimum.- Created regional Market Access function. Designed Market Access methodology derived.
Head, Arogya Parivar (Implementing For-Profit Social Business Model In India)
- Designed and implemented a then unique for-profit business model to improve access to medicines in low-income markets of rural India, a CEO-backed initiative involving new products, new distribution, face-to-face marketing, alliances with NGOs and local healthcare players. (http://www.youtube.com/watch?v=o6nS8gBM_WQ)- Introduced 70 medicines in 9.
Senior Vp Strategy, Business Development & Licensing - Head Asia-Pacific - Head Consumer Excellence
- Supported the growth of a USD 1.5 billion division through M&A, JV's, alliances, various agreements (co-manufacturing, technology in- and out- licenses, distribution...)- Developed strategic plans for division and group executive committees, that ultimately led to a divestiture of the division to Nestlé. - Managed Asia region. Created or expanded.
Senior Vp Latin America (I&B Division)
- Grew all markets in Latin America (US$ 250 million baby jars and cereals, baby accessories) and achieved record market shares in each country and segment, despite a very depressed economy in the continent, falling consumer purchasing power, diminishing births and intensified competition - Simplified organization from 7 sub-regions to 3 and implemented.
Vp And Gm Brazil, Argentina, Chile
- Developed all Consumer Health activities in Argentina, Brazil, Chile, Paraguay, Uruguay (US$100 million baby products, over-the-counter (OTC) drugs, medical nutrition, functional foods).- Turned around the Brazilian business after years of losses. Consolidated plants. Divested non-core businesses. Grew Medical Nutrition and OTC businesses by.
Director Business Development & Strategy Worldwide
Defined, organized and ran the 2002-2006 worldwide Strategic Plan for the Division (US$ 6 billion). Led numerous projects of acquisitions, divestitures and licensing (Poland, Brazil, Germany, France).
Vp M&A, Strategy - Worldwide Beverages Division
Coordinated the 2001-2005 Strategic Plan for the Worldwide Water Division (US$ 3 billion) and defined global strategies. Initiated and led alliances and acquisitions in Canada, the USA, Mexico, Brazil, Uruguay, Argentina, Portugal and Italy.
Cfo - Vp Finance, Strategy, M&A, Customer Service, It, Logistics (Usa, Canada)
Contributed to grow the US and Canadian sales from US$ 250 millions to US$ 600 millions through organic growth and 3 successfully integrated acquisitions (AquaPenn Spring Water, McKesson Water Products, Naya)
Associate Partner, Industrial & Consumer Products
- Sold, designed and implemented consulting engagements related to major transformations in multinational companies, predominantly in the mechanical and electronics industries (strategic analysis, business process reengineering (BPR), design and implementation of information systems, change management, M&A). Specialized in profitability turnaround, mergers.
Military Engineer (Ingénieur De L'Armement) - Military Service
Supported 3-star General Sandeau at DGA/DTEn in his mission of evaluating and procuring defense systems.
Colleagues at LiberaBio
Other employees you can reach at liberabio.com. View company contacts for 10 employees →
Daniel Perez Estevez
Colleague at Liberabio
Greater Vigo Metropolitan Area, Spain
View →
IR
Inma Rodríguez
Colleague at Liberabio
Greater Vigo Metropolitan Area, Spain
View →
LD
Ludmilla David De Moura
Colleague at Liberabio
Santiago De Compostela, Galicia, Spain, Spain
View →
MR
Marcos Rúa
Colleague at Liberabio
Santiago De Compostela, Galicia, Spain, Spain
View →
Olivier Jarry education
Master Of Business Administration (M.B.A.), Executive Mba, International Business
Executive Mba, International Business
Emba, International Business
Emba, International Business
Master Of Engineering - Meng, Defense Systems
Msc, Aerospace
Frequently asked questions about Olivier Jarry
Quick answers generated from the profile data available on this page.
What company does Olivier Jarry work for?
Olivier Jarry works for LiberaBio.
What is Olivier Jarry's role at LiberaBio?
Olivier Jarry is listed as Chief Executive Officer and Co-Founder at LiberaBio.
What is Olivier Jarry's email address?
AeroLeads has found 1 work email signal at @liberabio.com for Olivier Jarry at LiberaBio.
What is Olivier Jarry's phone number?
AeroLeads has found 1 phone signal(s) with area code 914 for Olivier Jarry at LiberaBio.
Where is Olivier Jarry based?
Olivier Jarry is based in New York, New York, United States while working with LiberaBio.
What companies has Olivier Jarry worked for?
Olivier Jarry has worked for Liberabio, Advantage Therapeutics Inc., Rational Vaccines, Os Therapies, and Atlas Advisors, Llc.
Who are Olivier Jarry's colleagues at LiberaBio?
Olivier Jarry's colleagues at LiberaBio include Daniel Perez Estevez, Inma Rodríguez, Ludmilla David De Moura, and Marcos Rúa.
How can I contact Olivier Jarry?
You can use AeroLeads to view verified contact signals for Olivier Jarry at LiberaBio, including work email, phone, and LinkedIn data when available.
What schools did Olivier Jarry attend?
Olivier Jarry holds Master Of Business Administration (M.B.A.), Executive Mba, International Business from Trium Global Executive Mba.
What skills is Olivier Jarry known for?
Olivier Jarry is listed with skills including Product Marketing, Marketing Management, International Business, Restructuring, Strategic Partnerships, Sales Growth, Mergers, and Executive Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial